Much lower. The fact that the fat boy and his clown posse haven't the balls to admit they failed again to get the FDA to approve IND status for Hemaxellerate will obliterate the stock when they announce this in DEC. I have seen only one other management team be as incredibly incompetent as Koos and Illichim. But that's the price you pay when you play the stinky pinkies.
News 
Market Data 
Discover 
